Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MYL

Mylan (MYL) Stock Price, News & Analysis

Mylan logo

About Mylan Stock (NASDAQ:MYL)

Key Stats

Today's Range
$15.86
$15.86
50-Day Range
$14.37
$15.86
52-Week Range
$12.75
$23.11
Volume
4,016 shs
Average Volume
6.49 million shs
Market Capitalization
$8.59 billion
P/E Ratio
29.92
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mylan Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

MYL MarketRank™: 

Mylan scored higher than 29% of companies evaluated by MarketBeat, and ranked 802nd out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mylan.

  • Earnings Growth

    Earnings for Mylan are expected to grow by 0.90% in the coming year, from $4.46 to $4.50 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mylan is 29.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.08.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mylan is 29.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.72.

  • Price to Earnings Growth Ratio

    Mylan has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Mylan has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for MYL.
  • Dividend Yield

    Mylan does not currently pay a dividend.

  • Dividend Growth

    Mylan does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MYL.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Mylan this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mylan insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.59% of the stock of Mylan is held by insiders.

  • Percentage Held by Institutions

    88.18% of the stock of Mylan is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mylan's insider trading history.
Receive MYL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mylan and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MYL Stock News Headlines

Melt-up warning
America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter Stansberry warned about in The End of America — and now he says we’ve entered a danger zone from which there may be no easy return.tc pixel
Hope Gas Ice Pavilion opens at Mylan Park
See More Headlines

MYL Stock Analysis - Frequently Asked Questions

Mylan (NASDAQ:MYL) released its quarterly earnings data on Friday, November, 6th. The company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.15. The firm's quarterly revenue was up .4% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mylan investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), NVIDIA (NVDA), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Netflix (NFLX) and Micron Technology (MU).

Company Calendar

Last Earnings
11/06/2020
Today
10/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MYL
CIK
1623613
Fax
N/A
Employees
35,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$4.42
Trailing P/E Ratio
29.92
Forward P/E Ratio
3.55
P/E Growth
2.01
Net Income
$16.80 million
Net Margins
2.35%
Pretax Margin
N/A
Return on Equity
20.43%
Return on Assets
7.72%

Debt

Debt-to-Equity Ratio
0.84
Current Ratio
0.93
Quick Ratio
0.53

Sales & Book Value

Annual Sales
$11.50 billion
Price / Sales
0.75
Cash Flow
$8.76 per share
Price / Cash Flow
1.81
Book Value
$23.02 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
541,546,000
Free Float
N/A
Market Cap
$8.59 billion
Optionable
Optionable
Beta
1.45
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MYL) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners